These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 17490778

  • 1. N-terminal pro-brain natriuretic peptide (NT-proBNP) in Type 2 diabetes with left ventricular dysfunction.
    Kim JY, Lee EY, Jee JH, Lee BW, Chung JH, Jeun ES, Min YK, Lee MS, Kim KW, Lee MK.
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S238-42. PubMed ID: 17490778
    [Abstract] [Full Text] [Related]

  • 2. NT-proBNP in normoalbuminuric patients with Type 2 diabetes mellitus.
    Andersen NH, Poulsen SH, Knudsen ST, Heickendorff L, Mogensen CE.
    Diabet Med; 2005 Feb; 22(2):188-95. PubMed ID: 15660737
    [Abstract] [Full Text] [Related]

  • 3. Diagnostic value of N-terminal pro-B-type natriuretic peptide (NT-proBNP) for left ventricular dysfunction in patients with chronic kidney disease stage 5 on haemodialysis.
    David S, Kümpers P, Seidler V, Biertz F, Haller H, Fliser D.
    Nephrol Dial Transplant; 2008 Apr; 23(4):1370-7. PubMed ID: 18089624
    [Abstract] [Full Text] [Related]

  • 4. Plasma N-terminal pro-brain natriuretic peptide: a marker of left ventricular hypertrophy in hypertrophic cardiomyopathy.
    Brito D, Matias JS, Sargento L, Cabral MJ, Madeira HC.
    Rev Port Cardiol; 2004 Dec; 23(12):1557-82. PubMed ID: 15732658
    [Abstract] [Full Text] [Related]

  • 5. Aminoterminal B-type pro-natriuretic peptide as a marker of recovery after high-risk coronary artery bypass grafting in patients with ischemic heart disease and severe impaired left ventricular function.
    Rothenburger M, Stypmann J, Bruch C, Wichter T, Hoppe M, Drees G, Berendes E, Huelsken G, Loeher A, Welp H, Röttger C, Schmid C, Scheld HH, Tjan TD.
    J Heart Lung Transplant; 2006 May; 25(5):596-602. PubMed ID: 16678040
    [Abstract] [Full Text] [Related]

  • 6. The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements.
    Tschöpe C, Kasner M, Westermann D, Gaub R, Poller WC, Schultheiss HP.
    Eur Heart J; 2005 Nov; 26(21):2277-84. PubMed ID: 16014646
    [Abstract] [Full Text] [Related]

  • 7. NT-proBNP levels in the evaluation of right ventricular dysfunction in patients with coronary artery disease and abnormal left ventricular wall motion: a magnetic resonance imaging study.
    Krittayaphong R, Boonyasirinant T, Saiviroonporn P, Udompunturak S.
    Coron Artery Dis; 2008 Nov; 19(7):481-7. PubMed ID: 18923244
    [Abstract] [Full Text] [Related]

  • 8. Cutoff values of NT-proBNP for the prediction of low functional capacity, decreased ejection fraction and cardiovascular events in patients with heart failure.
    Koç M, Bozkurt A, Yildiray-Sahin D, Unal I, Acartürk E.
    Cardiol J; 2009 Nov; 16(1):43-9. PubMed ID: 19130415
    [Abstract] [Full Text] [Related]

  • 9. Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide.
    Giallauria F, Cirillo P, Lucci R, Pacileo M, De Lorenzo A, D'Agostino M, Moschella S, Psaroudaki M, Del Forno D, Orio F, Vitale DF, Chiariello M, Vigorito C.
    Eur J Cardiovasc Prev Rehabil; 2008 Feb; 15(1):113-8. PubMed ID: 18277196
    [Abstract] [Full Text] [Related]

  • 10. Hyperthyroidism may affect serum N-terminal pro-B-type natriuretic peptide levels independently of cardiac dysfunction.
    Arikan S, Tuzcu A, Gokalp D, Bahceci M, Danis R.
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):202-7. PubMed ID: 17547691
    [Abstract] [Full Text] [Related]

  • 11. Elevated plasma N-terminal pro-brain natriuretic peptide levels in acute ischemic stroke.
    Iltumur K, Yavavli A, Apak I, Ariturk Z, Toprak N.
    Am Heart J; 2006 May; 151(5):1115-22. PubMed ID: 16644347
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Accuracy of N-terminal pro-brain natriuretic peptide in the identification of left ventricular dysfunction in high-risk asymptomatic patients.
    Romano S, Necozione S, Guarracini L, Fratini S, Cisternino P, di Orio F, Penco M.
    J Cardiovasc Med (Hagerstown); 2009 Mar; 10(3):238-44. PubMed ID: 19262210
    [Abstract] [Full Text] [Related]

  • 14. Correlation Between NT-pro BNP levels and left ventricular wall stress, sphericity index and extent of myocardial damage: a magnetic resonance imaging study.
    Krittayaphong R, Boonyasirinant T, Saiviroonporn P, Thanapiboonpol P, Nakyen S, Udompunturak S.
    J Card Fail; 2008 Oct; 14(8):687-94. PubMed ID: 18926441
    [Abstract] [Full Text] [Related]

  • 15. Serum N-terminal-pro-brain natriuretic peptide (NT-pro-BNP) and homocysteine levels in type 2 diabetic patients with asymptomatic left ventricular diastolic dysfunction.
    Görmüş U, Ozmen D, Ozmen B, Parildar Z, Ozdoğan O, Mutaf I, Bayindir O.
    Diabetes Res Clin Pract; 2010 Jan; 87(1):51-6. PubMed ID: 19932518
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The effect of coronary angioplasty on plasma NT-proBNP level in patients with and without arterial hypertension.
    Brzezinska U, El Mokhtari NE, Simon R, Tykarski A.
    Blood Press; 2006 Jan; 15(3):173-8. PubMed ID: 16864160
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. N-terminal pro-brain natriuretic peptide in cases with metabolic syndrome and its relationship with components of metabolic syndrome and left ventricular mass index.
    Sezen Y, Baş M, Demirbag R, Yildiz A, Celik H, Aksoy S.
    Clin Biochem; 2009 Oct; 42(15):1500-3. PubMed ID: 19615987
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.